Yesterday morning, a newly published paper was brought to my attention. It reports that use of the Prostate Health Index or phi test in a partially prospective study can and did change urologists’ opinions about whether selected patients really do or don’t need to have a prostate biopsy. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, Diagnosis, phi, Prostate Health Index, test | 4 Comments »
It will come as no great surprise to regular readers that your Sitemaster has been less than enthusiastic to date about the potential of the Prostate Health Index or phi test as a tool for assessment of risk for prostate cancer. However, new data is starting to give him slightly greater hope regarding the value of this test. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, phi, Prostate Health Index, risk, test | 18 Comments »
The National Institute for Health and Care Excellence (NICE) has issued draft guidance stating that two approved tests for risk of prostate cancer are not clinically useful in England. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PCA3, phi, Prostate Health Index, risk | 4 Comments »
In more data reported at ASCO yesterday afternoon, we got the first real look at what appears to be a helpful study designed to evaluate whether the Beckman Coulter Prostate Health Index (or phi) test is really able to identify men who are good candidates for active surveillance. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active, phi, prognosis, Prostate Health Index, surveillance | 5 Comments »
We’re a tad flummoxed by a media release from Northwestern Medicine in Chicago stating that it is “the first health care provider in the country to offer a new non-invasive blood test for prostate cancer that is nearly three times more accurate than the current standard prostate-specific antigen (PSA) blood test.” … READ MORE …
Filed under: Diagnosis, Risk | Tagged: phi, Prostate Health Index | 1 Comment »
Last April we reported on activities related to the development of a test known as the Prostate Health Index (PHI or phi), which has been tested for its potential as a tool to better identify men at risk for clinically significant prostate cancer as compared to men with potentially indolent disease. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Prostate Health Index, PSA, risk, [-2]pro-PSA | Leave a comment »
At the annual meeting of the European Association for Urology (which ends today in Barcelona), there was a sponsored symposium entitled, “Prostate Health Index (phi) – A simple blood test significantly improves on PSA in the selection of men for biopsy and is a major advance in prostate cancer risk assessment.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Diagnosis, phi, prognosis, Prostate Health Index, risk | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 